BeiGene, Ltd. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BeiGene, Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • BeiGene, Ltd. Operating Income (Loss) for the quarter ending December 31, 2024 was -$79.4M, a 79.3% increase year-over-year.
  • BeiGene, Ltd. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$568M, a 53% increase year-over-year.
  • BeiGene, Ltd. annual Operating Income (Loss) for 2024 was -$568M, a 53% increase from 2023.
  • BeiGene, Ltd. annual Operating Income (Loss) for 2023 was -$1.21B, a 32.5% increase from 2022.
  • BeiGene, Ltd. annual Operating Income (Loss) for 2022 was -$1.79B, a 24.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$568M +$640M +53% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$1.21B +$582M +32.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$1.79B -$351M -24.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 -$1.44B +$219M +13.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 -$1.66B -$698M -72.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 -$960M -$254M -36% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$706M -$607M -617% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$98.5M +$18.6M +15.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$117M -$60.3M -106% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$56.7M -$41M -260% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 -$15.8M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.